Decorin binding proteins A and B in the serodiagnosis of lyme disease in North America

Clinical and Vaccine Immunology

Volumn 21, Issue 10, 2014, Pages 1426-1436

  Arnaboldi, Paul M ^a,b   Sambir, Mariya ^a,b   Dattwyler, Raymond J ^a,b  

^a Biopeptides Corp   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; DECORIN BINDING PROTEIN A; DECORIN BINDING PROTEIN B; EPITOPE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; UNCLASSIFIED DRUG; ADHESIN; BACTERIAL ANTIGEN; BACTERIUM ANTIBODY; DDPB PROTEIN, BORRELIA BURGDORFERI;

AMINO TERMINAL SEQUENCE; ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIGEN DETECTION; ARTICLE; BACTERIAL STRAIN; BORRELIA BURGDORFERI; CONTROLLED STUDY; HUMAN; LYME DISEASE; MAJOR CLINICAL STUDY; MOLECULAR LIBRARY; NONHUMAN; NORTH AMERICA; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY; SERODIAGNOSIS; BLOOD; EARLY DIAGNOSIS; IMMUNOLOGY; PROCEDURES; SEROLOGY;

ADHESINS, BACTERIAL; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BORRELIA BURGDORFERI; EARLY DIAGNOSIS; EPITOPES, B-LYMPHOCYTE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LYME DISEASE; NORTH AMERICA; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS;

EID: 84907558328     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00383-14     Document Type: Article

References (30)

1. Stanek G, Wormser GP, Gray J, Strle F. 2012. Lyme borreliosis. Lancet 379:461-473. http://dx.doi.org/10.1016/S0140-6736(11)60103-7.
2. Steere AC. 2001. Lyme disease. N. Engl. J. Med. 345:115-125. http://dx.doi.org/10.1056/NEJM200107123450207.
3. Nadelman RB, Nowakowski J, Forseter G, Goldberg NS, Bittker S, Cooper D, Aguero-Rosenfeld M, Wormser GP. 1996. The clinical spectrum of early Lyme borreliosis in patients with culture-confirmed erythema migrans. Am. J. Med. 100:502-508.
4. Schutzer SE, Berger BW, Krueger JG, Eshoo MW, Ecker DJ, Aucott JN. 2013. Atypical erythema migrans in patients with PCR-positive Lyme disease. Emerg. Infect. Dis. 19:815-817. http://dx.doi.org/10.3201/eid1905.120796.
5. Centers for Disease Control and Prevention (CDC). 1995. Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Dis. MMWR Morb. Mortal. Wkly. Rep. 44:590-591.
6. Aguero-Rosenfeld ME, Wang G, Schwartz I, Wormser GP. 2005. Diagnosis of Lyme borreliosis. Clin. Microbiol. Rev. 18:484-509. http://dx.doi.org/10.1128/CMR.18.3.484-509.2005.
7. Liang FT, Steere AC, Marques AR, Johnson BJ, Miller JN, Philipp MT. 1999. Sensitive and specific serodiagnosis of Lyme disease by enzymelinked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi VlsE. J. Clin. Microbiol. 37:3990-3996.
8. Wormser GP, Dattwyler RJ, Shapiro ED, Halperin JJ, Steere AC, Klempner MS, Krause PJ, Bakken JS, Strle F, Stanek G, Bockenstedt L, Fish D, Dumler JS, Nadelman RB. 2006. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin. Infect. Dis. 43:1089-1134. http://dx.doi.org/10.1086/508667.
9. Wormser GP, Aguero-Rosenfeld ME, Nadelman RB. 1999. Lyme disease serology: problems and opportunities. JAMA 282:79-80. http://dx.doi.org/10.1001/jama.282.1.79.
10. Gomes-Solecki MJ, Wormser GP, Persing DH, Berger BW, Glass JD, Yang X, Dattwyler RJ. 2001. A first-tier rapid assay for the serodiagnosis of Borrelia burgdorferi infection. Arch. Intern. Med. 161:2015-2020. http://dx.doi.org/10.1001/archinte.161.16.2015.
11. Gomes-Solecki MJ, Wormser GP, Schriefer M, Neuman G, Hannafey L, Glass JD, Dattwyler RJ. 2002. Recombinant assay for serodiagnosis of Lyme disease regardless of OspA vaccination status. J. Clin. Microbiol. 40:193-197. http://dx.doi.org/10.1128/JCM.40.1.193-197.2002.
12. Nowakowski J, Schwartz I, Liveris D, Wang G, Aguero-Rosenfeld ME, Girao G, McKenna D, Nadelman RB, Cavaliere LF, Wormser GP, Lyme Disease Study Group. 2001. Laboratory diagnostic techniques for patients with early Lyme disease associated with erythema migrans: a comparison of different techniques. Clin. Infect. Dis. 33:2023-2027. http://dx.doi.org/10.1086/324490.
13. Bacon RM, Biggerstaff BJ, Schriefer ME, Gilmore RD, Jr, Philipp MT, Steere AC, Wormser GP, Marques AR, Johnson BJ. 2003. Serodiagnosis of Lyme disease by kinetic enzyme-linked immunosorbent assay using recombinant VlsE1 or peptide antigens of Borrelia burgdorferi compared with 2-tiered testing using whole-cell lysates. J. Infect. Dis. 187:1187-1199. http://dx.doi.org/10.1086/374395.
14. Coleman AS, Rossmann E, Yang X, Song H, Lamichhane CM, Iyer R, Schwartz I, Pal U. 2011. BBK07 immunodominant peptides as serodiagnostic markers of Lyme disease. Clin. Vaccine Immunol. 18:406-413. http://dx.doi.org/10.1128/CVI.00461-10.
15. Gomes-Solecki MJC, Meirelles L, Glass J, Dattwyler RJ. 2007. Epitope length, genospecies dependency, and serum panel effect in the IR6 enzyme-linked immunosorbent assay for detection of antibodies to Borrelia burgdorferi. Clin. Vaccine Immunol. 14:875-879. http://dx.doi.org/10.1128/CVI.00122-07.
16. Arnaboldi PM, Seedarnee R, Sambir M, Callister SM, Imparato JA, Dattwyler RJ. 2013. Outer surface protein C peptide derived from Borrelia burgdorferi sensu stricto as a target for serodiagnosis of early Lyme disease. Clin. Vaccine Immunol. 20:474-481. http://dx.doi.org/10.1128/CVI.00608-12.
17. Signorino G, Arnaboldi PM, Petzke MM, Dattwyler RJ. 2014. Identification of OppA2 linear epitopes as serodiagnostic markers for Lyme disease. Clin. Vaccine Immunol. 21:704-711. http://dx.doi.org/10.1128/CVI.00792-13.
18. Heikkilä T, Huppertz HI, Seppälä I, Sillanpää H, Saxen H, Lahdenne P. 2003. Recombinant or peptide antigens in the serology of Lyme arthritis in children. J. Infect. Dis. 187:1888-1894. http://dx.doi.org/10.1086/375371.
19. Wormser GP, Schriefer M, Aguero-Rosenfeld ME, Levin A, Steere AC, Nadelman RB, Nowakowski J, Marques A, Johnson BJ, Dumler JS. Single-tier testing with the C6 peptide ELISA kit compared with two-tier testing for Lyme disease. Diagn. Microbiol. Infect. Dis. http://dx.doi.org/10.1016/j.diagmicrobio.2012.09.003.
20. Ohnishi J, Schneider B, Messer WB, Piesman J, de Silva AM. 2003. Genetic variation at the vlsE locus of Borrelia burgdorferi within ticks and mice over the course of a single transmission cycle. J. Bacteriol. 185:4432-4441. http://dx.doi.org/10.1128/JB.185.15.4432-4441.2003.
21. Roberts WC, Mullikin BA, Lathigra R, Hanson MS. 1998. Molecular analysis of sequence heterogeneity among genes encoding decorin binding proteins A and B of Borrelia burgdorferi sensu lato. Infect. Immun. 66: 5275-5285.
22. Hanson MS, Cassatt DR, Guo BP, Patel NK, McCarthy MP, Dorward DW, Höök M. 1998. Active and passive immunity against Borrelia burgdorferi decorin binding protein A (DbpA) protects against infection. Infect. Immun. 66:2143-2153.
23. Hagman KE, Yang X, Wikel SK, Schoeler GB, Caimano MJ, Radolf JD, Norgard MV. 2000. Decorin-binding protein A (DbpA) of Borrelia burgdorferi is not protective when immunized mice are challenged via tick infestation and correlates with the lack of DbpA expression by B. burgdorferi in ticks. Infect. Immun. 68:4759-4764. http://dx.doi.org/10.1128/IAI.68.8.4759-4764.2000.
24. Hanson MS, Patel NK, Cassatt DR, Ulbrandt ND. 2000. Evidence for vaccine synergy between Borrelia burgdorferi decorin binding protein A and outer surface protein A in the mouse model of Lyme borreliosis. Infect. Immun. 68:6457-6460. http://dx.doi.org/10.1128/IAI.68.11.6457 -6460.2000.
25. Heikkilä T, Seppälä I, Saxen H, Panelius J, Yrjänäinen H, Lahdenne P. 2002. Species-specific serodiagnosis of Lyme arthritis and neuroborreliosis due to Borrelia burgdorferi sensu stricto, B. afzelii, and B. garinii by using decorin binding protein A. J. Clin. Microbiol. 40:453-460. http://dx.doi.org/10.1128/JCM.40.02.453-460.2002.
26. Cinco M, Ruscio M, Rapagna F. 2000. Evidence of Dbps (decorin binding proteins) among European strains of Borrelia burgdorferi sensu lato and in the immune response of LB patient sera. FEMS Microbiol. Lett. 183:111-114. http://dx.doi.org/10.1111/j.1574-6968.2000.tb08942.x.
27. Liang FT, Yan J, Mbow ML, Sviat SL, Gilmore RD, Mamula M, Fikrig E. 2004. Borrelia burgdorferi changes its surface antigenic expression in response to host immune responses. Infect. Immun. 72:5759-5767. http://dx.doi.org/10.1128/IAI.72.10.5759-5767.2004.
28. Xu Y, Bruno JF, Luft BJ. 2008. Profiling the humoral immune response to Borrelia burgdorferi infection with protein microarrays. Microb. Pathog. 45:403-407. http://dx.doi.org/10.1016/j.micpath.2008.09.006; http://dx.doi.org/10.1016/j.micpath.2008.09.006.
29. Goettner G, Schulte-Spechtel U, Hillermann R, Liegl G, Wilske B, Fingerle V. 2005. Improvement of Lyme borreliosis serodiagnosis by a newly developed recombinant immunoglobulin G (IgG) and IgM line immunoblot assay and addition of VlsE and DbpA homologues. J. Clin. Microbiol. 43:3602-3609. http://dx.doi.org/10.1128/JCM.43.8.3602-3609.2005.
30. Schulte-Spechtel U, Fingerle V, Goettner G, Rogge S, Wilske B. 2006. Molecular analysis of decorin-binding protein A (DbpA) reveals five major groups among European Borrelia burgdorferi sensu lato strains with impact for the development of serological assays and indicates lateral gene transfer of the dbpA gene. Int. J. Med. Microbiol. 296(Suppl 40):250-266. http://dx.doi.org/10.1016/j.ijmm.2006.01.006.